90 Barrett's Esophagus Surveillance and Risk of Death From Esophageal Adenocarcinoma: A Case-Control Study

Barrett’s esophagus and reflux disease

“…These data indicate that the incidence of neoplasia in nondysplastic Barrett's esophagus is lower than previously reported, therefore longer surveillance intervals in this low risk cohort of patients may be justified. The other study, from Corley et al, is the first community based case-control study to investigate the association between surveillance for Barrett's esophagus and survival from esophageal adenocarcinoma (EAC) [3]. Based on a population of 3.3 million electronically tracked members, the study included 35 patients who died from EAC having had a diagnosis of Barrett's esophagus at least 6 months prior to the diagnosis of cancer and 135 controls with Barrett's esophagus who did not die from EAC.…”